Ha habido 50 transacciones internas recientes registradas para Coya Therapeutics, Inc. (COYA), incluyendo 45 compras y 2 ventas. El total de compras internas fue valorado en $14.2M y el total de ventas internas en $594.49K.
Internos destacados con actividad reciente incluyen Snyder David S, Berman Howard, Grossman Fred. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — COYA
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-01-22 |
Snyder David S |
Chief Financial Officer |
Concesión de RSU |
140,041 |
$4.73 |
$662.39K |
140,041 |
| 2026-01-22 |
Berman Howard |
Executive Chairman |
Concesión de RSU |
15,257 |
$4.73 |
$72.17K |
15,257 |
| 2026-01-22 |
Grossman Fred |
Chief Medical Officer |
Concesión de RSU |
140,041 |
$4.73 |
$662.39K |
140,041 |
| 2026-01-22 |
Swaminathan Arun |
Chief Executive Officer |
Concesión de RSU |
293,983 |
$4.73 |
$1.39M |
293,983 |
| 2026-01-02 |
Ross Wilbur L Jr |
Director |
Concesión de RSU |
10,000 |
$5.65 |
$56.5K |
10,000 |
| 2026-01-02 |
Goldstein Dov A Md |
Director |
Concesión de RSU |
10,000 |
$5.65 |
$56.5K |
10,000 |
| 2026-01-02 |
Weinand Dieter |
Director |
Concesión de RSU |
10,000 |
$5.65 |
$56.5K |
10,000 |
| 2026-01-02 |
Villalobos Anabella |
Director |
Concesión de RSU |
10,000 |
$5.65 |
$56.5K |
10,000 |
| 2026-01-02 |
Lee Ann |
Director |
Concesión de RSU |
10,000 |
$5.65 |
$56.5K |
10,000 |
| 2025-08-18 |
Goldstein Dov A Md |
Director |
Ejercicio de Opciones (Venta) |
17,557 |
$1.09 |
$19.14K |
- |
| 2025-02-25 |
Ross Wilbur L Jr |
Director |
Concesión de RSU |
5,000 |
$5.97 |
$29.85K |
5,000 |
| 2025-02-25 |
Goldstein Dov A Md |
Director |
Concesión de RSU |
5,000 |
$5.97 |
$29.85K |
5,000 |
| 2025-02-25 |
Weinand Dieter |
Director |
Concesión de RSU |
5,000 |
$5.97 |
$29.85K |
5,000 |
| 2025-02-25 |
Villalobos Anabella |
Director |
Concesión de RSU |
5,000 |
$5.97 |
$29.85K |
5,000 |
| 2025-02-25 |
Lee Ann |
Director |
Concesión de RSU |
5,000 |
$5.97 |
$29.85K |
5,000 |
| 2025-01-09 |
Snyder David S |
Chief Financial Officer |
Concesión de RSU |
140,562 |
$6.07 |
$853.21K |
140,562 |
| 2025-01-09 |
Berman Howard |
Director |
Concesión de RSU |
150,602 |
$6.07 |
$914.15K |
150,602 |
| 2025-01-09 |
Grossman Fred |
Chief Medical Officer |
Concesión de RSU |
140,562 |
$6.07 |
$853.21K |
140,562 |
| 2025-01-09 |
Swaminathan Arun |
Chief Executive Officer |
Concesión de RSU |
240,964 |
$6.07 |
$1.46M |
240,964 |
| 2025-01-01 |
Ross Wilbur L Jr |
Director |
Concesión de RSU |
5,000 |
$5.73 |
$28.65K |
5,000 |
| 2025-01-01 |
Goldstein Dov A Md |
Director |
Concesión de RSU |
5,000 |
$5.73 |
$28.65K |
5,000 |
| 2025-01-01 |
Weinand Dieter |
Director |
Concesión de RSU |
5,000 |
$5.73 |
$28.65K |
5,000 |
| 2025-01-01 |
Villalobos Anabella |
Director |
Concesión de RSU |
5,000 |
$5.73 |
$28.65K |
5,000 |
| 2025-01-01 |
Lee Ann |
Director |
Concesión de RSU |
5,000 |
$5.73 |
$28.65K |
5,000 |
| 2024-11-14 |
Snyder David S |
Chief Financial Officer |
Compra Informativa |
1,800 |
$7.19 |
$12.93K |
8,800 |
| 2024-11-13 |
Swaminathan Arun |
Chief Executive Officer |
Compra Informativa |
5,000 |
$7.36 |
$36.8K |
10,000 |
| 2024-11-11 |
Grossman Fred |
Chief Medical Officer |
Compra Informativa |
2,710 |
$7.37 |
$19.97K |
2,710 |
| 2024-11-11 |
Swaminathan Arun |
Chief Executive Officer |
Compra Informativa |
5,000 |
$7.34 |
$36.69K |
5,000 |
| 2024-08-19 |
Swaminathan Arun |
Director |
Disposición |
70,596 |
$8.15 |
$575.36K |
- |
| 2024-06-03 |
Snyder David S |
Chief Financial Officer |
Concesión de RSU |
70,596 |
$8.15 |
$575.36K |
70,596 |
| 2024-06-03 |
Berman Howard |
Chief Executive Officer |
Concesión de RSU |
163,663 |
$8.15 |
$1.33M |
163,663 |
| 2024-06-03 |
Grossman Fred |
Chief Medical Officer |
Concesión de RSU |
70,596 |
$8.15 |
$575.36K |
70,596 |
| 2024-01-31 |
Snyder David S |
Chief Financial Officer |
Concesión de RSU |
81,819 |
$5.90 |
$482.73K |
81,819 |
| 2024-01-31 |
Berman Howard |
Chief Executive Officer |
Concesión de RSU |
189,680 |
$5.90 |
$1.12M |
189,680 |
| 2024-01-31 |
Grossman Fred |
Chief Medical Officer |
Concesión de RSU |
74,069 |
$5.90 |
$437.01K |
74,069 |
| 2024-01-02 |
Ross Wilbur L Jr |
Director |
Concesión de RSU |
10,000 |
$6.97 |
$69.7K |
10,000 |
| 2024-01-01 |
Goldstein Dov A Md |
Director |
Concesión de RSU |
5,000 |
$7.41 |
$37.05K |
5,000 |
| 2024-01-01 |
Weinand Dieter |
Director |
Concesión de RSU |
5,000 |
$7.41 |
$37.05K |
5,000 |
| 2024-01-01 |
Garren Hideki |
Director |
Concesión de RSU |
5,000 |
$7.41 |
$37.05K |
5,000 |
| 2024-01-01 |
Villalobos Anabella |
Director |
Concesión de RSU |
5,000 |
$7.41 |
$37.05K |
5,000 |
| 2024-01-01 |
Lee Ann |
Director |
Concesión de RSU |
5,000 |
$7.41 |
$37.05K |
5,000 |
| 2023-12-19 |
Ross Wilbur L Jr |
Director |
Desconocido |
- |
- |
- |
165,016 |
| 2023-08-22 |
Lee Ann |
Director |
Compra Informativa |
1,000 |
$3.62 |
$3.62K |
17,479 |
| 2023-08-18 |
Weinand Dieter |
Director |
Desconocido |
- |
- |
- |
- |
| 2023-08-18 |
Weinand Dieter |
Director |
Concesión de RSU |
10,000 |
$3.43 |
$34.3K |
10,000 |
| 2023-07-17 |
Grossman Fred |
Officer |
Desconocido |
- |
- |
- |
- |
| 2023-07-17 |
Grossman Fred |
Chief Medical Officer |
Concesión de RSU |
74,069 |
$4.25 |
$314.79K |
74,069 |
| 2023-02-27 |
Snyder David S |
Chief Financial Officer |
Concesión de RSU |
115,000 |
$3.85 |
$442.75K |
115,000 |
| 2023-02-27 |
Hepner Adrian |
Chief Medical Officer |
Concesión de RSU |
115,000 |
$3.85 |
$442.75K |
115,000 |
| 2023-02-27 |
Berman Howard |
Chief Executive Officer |
Concesión de RSU |
165,000 |
$3.85 |
$635.25K |
165,000 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
